×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
YDES – yd bio limited - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
YDES
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
09:00 am
ydes
YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection
High
Report
YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection
11/24
09:00 am
ydes
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics
Medium
Report
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics
11/5
08:30 am
ydes
YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA-Methylation Blood Test for Post-Treatment Breast Cancer Monitoring
Medium
Report
YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA-Methylation Blood Test for Post-Treatment Breast Cancer Monitoring
10/20
10:20 am
ydes
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
Medium
Report
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
10/10
08:37 am
ydes
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities
Medium
Report
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities
9/30
10:15 pm
ydes
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results [Yahoo! Finance]
High
Report
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results [Yahoo! Finance]
9/30
05:25 pm
ydes
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
High
Report
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/17
05:25 pm
ydes
Form 6-K YD Bio Ltd For: Nov 17
High
Report
Form 6-K YD Bio Ltd For: Nov 17
9/30
04:31 pm
ydes
Form 6-K YD Bio Ltd For: Jun 30
High
Report
Form 6-K YD Bio Ltd For: Jun 30
9/26
08:30 am
ydes
Form 6-K YD Bio Ltd For: Sep 26
High
Report
Form 6-K YD Bio Ltd For: Sep 26
9/19
04:30 pm
ydes
Form 6-K YD Bio Ltd For: Sep 19
Medium
Report
Form 6-K YD Bio Ltd For: Sep 19
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: